Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07579325 · ClinicalTrials.gov registry record
Lipid Screening Study
A clinical trial, sponsored by University of Central Florida.
- Recruiting
- Registry status
- 30
- Enrollment target
NCT07579325 is a clinical trial that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 30 participants.
The verdict
NCT07579325 is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to estimate the prevalence of elevated Lipoprotein (a) in an adult primary care population and to describe the distribution of atherogenic lipid markers within this cohort. This pilot study will provide preliminary data to inform future cardiovascular risk assessment initiatives in primary care.
Interventions
- OTHER Venipuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-05-05 |
| Est. Completion | 2026-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07579325
The ClinicalTrials.gov registry entry for NCT07579325 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Venipuncture is the first listed.
NCT07579325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07579325 about?
NCT07579325 is a clinical study titled "Lipid Screening Study". The purpose of this pilot study is to estimate the prevalence of elevated Lipoprotein (a) in an adult primary care population and to describe the distribution of atherogenic lipid markers within this cohort. This pilot study will provide preliminary data to inform future cardiovascular risk assessme...
What is the current status of trial NCT07579325?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2026-05-05. Estimated completion is 2026-08-01.
What interventions are being tested in trial NCT07579325?
The interventions under investigation include: Venipuncture (OTHER).
Who is sponsoring clinical trial NCT07579325?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.